Literature DB >> 6607096

Anti-IgA-mediated transfusion reactions in Canada.

C Laschinger, F A Shepherd, D H Naylor.   

Abstract

During a 6-year period (1977 to 1982) blood samples from 152 Canadian patients were referred to the national reference laboratory of the Canadian Red Cross Society because the referring hospitals had not been able to determine the cause of the patients' severe nonhemolytic transfusion reactions. Twenty-one patients were found to be IgA deficient, and 12 of them had strong class-specific anti-IgA antibodies, which were presumed to have been responsible for the reactions. The spectrum of symptoms that accompanied these violent reactions was documented for 10 of the patients. As a probable minimum, the incidence of anti-IgA-mediated reactions averaged 1.3 per million units of blood or blood products transfused during this period.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607096      PMCID: PMC1875872     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  18 in total

1.  Febrile, nonhemolytic transfusion reactions and the limited role of leukoagglutinins in their etiology.

Authors:  S V KEVY; P J SCHMIDT; M H McGINNISS; W G WORKMAN
Journal:  Transfusion       Date:  1962 Jan-Feb       Impact factor: 3.157

2.  Transfusion reactions associated with anti-IgA antibodies: report of four cases and review of the literature.

Authors:  A A Pineda; H F Taswell
Journal:  Transfusion       Date:  1975 Jan-Feb       Impact factor: 3.157

3.  The significance of the presence of anti-IgA antibodies in individuals with an IgA deficiency.

Authors:  J H Nadorp; M Voss; W C Buys; P J van Munster; J H van Tongeren; R C Aalberse; E van Loghem
Journal:  Eur J Clin Invest       Date:  1973-07       Impact factor: 4.686

4.  IgA-induced anaphylactic transfusion reactions: a report of four cases.

Authors:  J Leikola; J Koistinen; M Lehtinen; M Virolainen
Journal:  Blood       Date:  1973-07       Impact factor: 22.113

5.  Anaphylactic transfusion reactions associated with anti-IgA antibody.

Authors:  A P Schmidt; H F Taswell; G J Gleich
Journal:  N Engl J Med       Date:  1969-01-23       Impact factor: 91.245

6.  Serologic specificity of hun anti-IgA and its significance in transfusion.

Authors:  G N Vyas; L Holmdahl; H A Perkins; H H Fudenberg
Journal:  Blood       Date:  1969-11       Impact factor: 22.113

7.  Serological investigations of 1,358 transfusion reactions in 74,000 transfusions.

Authors:  S Ahrons; F Kissmeyer-Nielsen
Journal:  Dan Med Bull       Date:  1968-11

8.  Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA.

Authors:  G N Vyas; H A Perkins; Y M Yang; G K Basantani
Journal:  J Lab Clin Med       Date:  1975-05

9.  Anaphylactic reactions to IgA: a difficult transfusion problem.

Authors:  W V Miller; P V Holland; E Sugarbaker; W Strober; T A Waldmann
Journal:  Am J Clin Pathol       Date:  1970-10       Impact factor: 2.493

10.  Nonhemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes.

Authors:  H A Perkins; R Payne; J Ferguson; M Wood
Journal:  Vox Sang       Date:  1966 Sep-Oct       Impact factor: 2.144

View more
  3 in total

1.  Long-term follow-up of anti-IgA antibodies in healthy IgA-deficient adults.

Authors:  S Koskinen; H Tölö; M Hirvonen; J Koistinen
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

Review 2.  Physiology of IgA and IgA deficiency.

Authors:  C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

Review 3.  An update on the use of immunoglobulin for the treatment of immunodeficiency disorders.

Authors:  Stephanie Albin; Charlotte Cunningham-Rundles
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.